← Back to Patent Explorer
US4137223A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of preserving blood plasma II

Assignee: Edward Shanbrom Inc
•
Filing: 1977-09-19
•
Granted: 1979-01-30
•
Expires: 1997-09-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Polyethylene glycol or poly(oxyethylene)poly(oxypropylene) glycol block copolymers or both and heparin in a suitable buffer, such as citrated saline, are added to blood plasma to preserve and protect blood coagulation factors and other proteins.

Inventors

  • 👤 Edward Shanbrom
  • 👤 Robert C. Bishop

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:29
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/16; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 119 words
The method of preserving blood plasma coagulation factors and other proteins during freezing and thawing of plasma for improving the recovery of coagulation proteins thereafter comprising the steps of: (a) adding to whole, fresh blood plasma a preservative solution consisting essentially of heparin and alpha-hydroxy-omega-hydroxy-poly(oxyethylene)poly(oxypropylene)poly(oxyethylene) block copolymer or mixtures of the same with polyethylene glycol to a concentration of from about 0.1 to about 25 grams of said polyol and from about 10 to about 2000 units of heparin per liter of plasma; (b) thereafter freezing the blood plasma containing said preservative; and (c) thereafter thawing the frozen blood plasma containing the preservative solution to recover therefrom plasma cryoprecipitate from which plasma proteins can be recovered in improved yield.
Claim 2
Independent Claim 119 words
The method of preserving blood plasma coagulation factors and other proteins during freezing and thawing of plasma for improving the recovery of coagulation proteins thereafter comprising the steps of: (a) adding to whole, fresh blood plasma a preservative solution consisting essentially of heparin and alpha-hydroxy-omega-hydroxy-poly(oxyethylene)poly(oxypropylene)poly(oxyethylene) block copolymer or mixtures of the same with polyethylene glycol to a concentration of from about 0.1 to about 25 grams of said polyol and from about 10 to about 2000 units of heparin per liter of plasma; (b) thereafter freezing the blood plasma containing said preservative; and (c) thereafter thawing the frozen blood plasma containing the preservative solution to recover therefrom plasma cryoprecipitate from which plasma proteins can be recovered in improved yield.

References Cited (Backward Citations)

US3770631A Cited
US4073886A Cited
US4025500A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-01-29 1982-07-31 1983-01-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-01-29 1986-07-31 1987-01-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-01-29 1990-07-31 1991-01-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag